Cochlear Limited (ASX:COH)
312.83
-1.18 (-0.38%)
Jul 25, 2025, 4:10 PM AEST
Cochlear Revenue
Cochlear had revenue of 1.17B AUD in the half year ending December 30, 2024, with 32.38% growth. This brings the company's revenue in the last twelve months to 2.31B, up 7.42% year-over-year. In the fiscal year ending June 30, 2024, Cochlear had annual revenue of 2.24B with 15.47% growth.
Revenue (ttm)
2.31B
Revenue Growth
+7.42%
P/S Ratio
8.86
Revenue / Employee
457.48K
Employees
5,097
Market Cap
20.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
Jun 30, 2020 | 1.32B | -106.10M | -7.44% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |
Regis Healthcare | 1.10B |
Cochlear News
- 10 days ago - Australia news live: Albanese in Chengdu for last leg of China visit; German backpacker leaves hospital after outback ordeal - The Guardian
- 11 days ago - Cochlear CEO calls for tax shake-up to boost R&D - The Australian Financial Review
- 19 days ago - Cochlear Launches World's First and Only Smart Cochlear Implant System - PRNewsWire
- 23 days ago - Cochlear takes fast lane as it brings new hearing device to Chinese market - South China Morning Post
- 6 weeks ago - ASX 200 LIVE: ASX pares gains; Cettire dives 25pc after reporting weak US demand - The Australian Financial Review
- 6 weeks ago - Starkey and MED-EL Announce All-New DualSync Partnership to Advance Bluetooth Connectivity for Cochlear Implant Users - Business Wire
- 7 weeks ago - Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™ - PRNewsWire
- 2 months ago - Labor takes $27m stake in breakthrough eye biotech - The Australian Financial Review